Regenosca announces completion of First‑in‑Human clinical trial Lausanne, Switzerland – December 1, 2025 Regenosca is proud to announce the successful...
Regenosca launches the STAMP Project to advance manufacturing of TissueSpan Lausanne, Switzerland – September 12, 2025 - Regenosca is pleased...
Regenosca publishes new preclinical research supporting TissueSpan Lausanne, Switzerland – February 12, 2025 - Regenosca is pleased to announce the...
Regenosca is accepted into the SFITS Accelerator Program Lausanne, Switzerland – January 30, 2025 - Regenosca is proud to announce...
Regenosca closes CHF 1 million pre-seed round to demonstrate endoscopic delivery of TissueSpan implants. Lausanne, Switzerland - July 22, 2024...
Aydin Kurt-Elli was appointed as a new board member of Regenosca SA. His experience as an entrepreneur, his knowledge in...
We are happy to announce that Regenosca has obtained the Innosuisse certificate! The certification represents the successful completion of the...
Networking with amazing Swiss startups, renowned investors and epxerts in the field during a one week roadshow in Boston. This...
Congratulations to Dr Ganesh Vythilingam (University Malaya Medical Center) who won a moderated poster award presenting Regenosca’s TissueSpan technology at...
Our CEO Eva-Maria Balet pitched during the Medtech Part II cluster. Thanks to the De Vigier Foundation for a very...
FROM BENCH TO BEDSIDE – A bioengineered collagen implant for urethral stricture repair This summer we have achieved a significant...
Recruitment has started for our first-in-man study. Our bioengineered collagen implant will be used as an alternative biomaterial to buccal...
Regenosca SA
Avenue de Sevelin 13C
1004 Lausanne